Roche (RHHBY) announced the launch of the cobas eplex respiratory pathogen panel 3, a new diagnostic test designed to detect a broad spectrum of viruses and bacteria that cause respiratory illness. The test is now available in countries accepting the CE mark.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY:
- Cantor sees Scholar Rock dominating SMA market after Genentech news
- Cantor sees Scholar Rock dominating SMA market after Genentech drops out
- Trump Trade: President issues short-term waiver of Jones Act
- Trump claims TrumpRx website offers lowest prices, review says not so, NYT says
- Roche announces FDA categorized its Ionify steroid assays